Fresenius SE & Co KGaA (FRE)-Financial and Strategic SWOT Analysis Review
May 2017
57
About the Report
About the Report
Fresenius SE & Co KGaA (FRE)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes machines for hemodialysis, acute dialysis and peritoneal dialysis; solutions for infusion therapy; dialysis care services; Spectra laboratories; liver support therapy services; and provision projects and services for hospitals and other health care facilities. It also operates and manages acute care and postacute care hospitals in Germany through Helios Kliniken Group. Its major manufacturing plants are in the US, Germany, China, Sweden and Japan. Fresenius conducts operations in Asia-Pacific, Europe, Africa and the Americas. The company is headquartered in Bad Homburg, Hessen, Germany.
Fresenius SE & Co KGaA Key Recent Developments
Mar 20,2017: Fresenius Helios opens new hospital building in Duisburg
Jan 31,2017: Fresenius Medical Care reaches agreement on outstanding payments
Jan 26,2017: U.S. District Court Issues Preliminary Injunction Against Premium Assistance Regulation
Jan 13,2017: Fresenius Medical Care Announces Leadership Change in North America
Dec 22,2016: Fresenius Helios receives antitrust approval to acquire Quironsalud
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Companies
Nipro Corp, Geratherm Medical AG, DaVita Inc, Behn Meyer Europe GmbH, Baxter International Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
Fresenius SE & Co KGaA-Key Facts 6
Fresenius SE & Co KGaA-Key Employees 7
Fresenius SE & Co KGaA-Key Employee Biographies 8
Fresenius SE & Co KGaA-Major Products and Services 9
Fresenius SE & Co KGaA-Medical Equipment Pipeline Products Data 11
Fresenius SE & Co KGaA Pipeline Products by Equipment Type 11
Fresenius SE & Co KGaA Pipeline Products by Development Stage 12
Fresenius SE & Co KGaA-History 14
Fresenius SE & Co KGaA-Company Statement 17
Fresenius SE & Co KGaA-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Section 2-Company Analysis 23
Fresenius SE & Co KGaA-Business Description 23
Business Description-Fresenius Helios 23
Fresenius Helios-Overview 23
Fresenius Helios-Financials 23
Fresenius Helios-Capital Expenditure 23
Business Description-Fresenius Kabi 23
Fresenius Kabi-Overview 23
Fresenius Kabi-Financials 24
Fresenius Kabi-Capital Expenditure 24
Business Description-Fresenius Medical Care 24
Fresenius Medical Care-Overview 24
Fresenius Medical Care-Financials 24
Fresenius Medical Care-Capital Expenditure 24
Business Description-Fresenius Vamed 24
Fresenius Vamed-Overview 24
Fresenius Vamed-Financials 24
Fresenius Vamed-Capital Expenditure 24
Fresenius SE & Co KGaA-Corporate Strategy 25
Fresenius SE & Co KGaA-SWOT Analysis 26
SWOT Analysis-Overview 26
Fresenius SE & Co KGaA-Strengths 26
Fresenius SE & Co KGaA-Weaknesses 27
Fresenius SE & Co KGaA-Opportunities 28
Fresenius SE & Co KGaA-Threats 29
Fresenius SE & Co KGaA-Key Competitors 30
Section 3-Company Financial Ratios 31
Financial Ratios-Capital Market Ratios 31
Financial Ratios-Annual Ratios 32
Performance Chart 35
Financial Performance 35
Financial Ratios-Interim Ratios 36
Financial Ratios-Ratio Charts 37
Section 4-Company's Lifesciences Financial Deals and Alliances 38
Fresenius SE & Co KGaA, Medical Equipment, Deals By Year, 2011 to YTD 2017 38
Fresenius SE & Co KGaA, Medical Equipment, Deals By Type, 2011 to YTD 2017 39
Fresenius SE & Co KGaA, Recent Deals Summary 40
Section 5-Company's Recent Developments 41
Apr 04, 2017: Award as "Great Place to Work" in the Dominican Republic 41
Mar 20, 2017: Fresenius Helios opens new hospital building in Duisburg 42
Mar 10, 2017: Fresenius Kabi builds new warehouse at Blonie production site 43
Feb 22, 2017: Fresenius Medical Care delivers strong 2016 results and sets ambitious growth targets for 2017 44
Jan 31, 2017: Fresenius Medical Care reaches agreement on outstanding payments 47
Jan 26, 2017: U.S. District Court Issues Preliminary Injunction Against Premium Assistance Regulation 48
Jan 13, 2017: Statement of Fresenius Medical Care North America Regarding U.S. Court Ruling Granting Temporary Restraining Order 49
Jan 13, 2017: Fresenius Medical Care Announces Leadership Change in North America 50
Dec 20, 2016: Schuldschein Loans of EUR1 billion placed 51
Dec 02, 2016: Change in Investor Relations Management-Dr. Dominik Heger joins Fresenius Medical Care 52
Section 6-Appendix 53
Methodology 53
Ratio Definitions 53
About GlobalData 57
Contact Us 57
Disclaimer 57
List of Figure
List of Figures
Fresenius SE & Co KGaA Pipeline Products by Equipment Type 11
Fresenius SE & Co KGaA Pipeline Products by Development Stage 12
Fresenius SE & Co KGaA, Performance Chart (2012-2016) 35
Fresenius SE & Co KGaA, Ratio Charts 37
Fresenius SE & Co KGaA, Medical Equipment, Deals By Year, 2011 to YTD 2017 38
Fresenius SE & Co KGaA, Medical Equipment, Deals by Type, 2011 to YTD 2017 39
List of Table
List of Tables
Fresenius SE & Co KGaA, Key Facts 6
Fresenius SE & Co KGaA, Key Employees 7
Fresenius SE & Co KGaA, Key Employee Biographies 8
Fresenius SE & Co KGaA, Major Products and Services 9
Fresenius SE & Co KGaA Pipeline Products by Equipment Type 11
Fresenius SE & Co KGaA Number of Pipeline Products by Development Stage 12
Fresenius SE & Co KGaA Pipeline Products Summary by Development Stage 13
Fresenius SE & Co KGaA, History 14
Fresenius SE & Co KGaA, Other Locations 18
Fresenius SE & Co KGaA, Subsidiaries 18
Fresenius SE & Co KGaA, Key Competitors 30
Fresenius SE & Co KGaA, Ratios based on current share price 31
Fresenius SE & Co KGaA, Annual Ratios 32
Fresenius SE & Co KGaA, Annual Ratios (Cont...1) 33
Fresenius SE & Co KGaA, Annual Ratios (Cont...2) 34
Fresenius SE & Co KGaA, Interim Ratios 36
Fresenius SE & Co KGaA, Medical Equipment, Deals By Year, 2011 to YTD 2017 38
Fresenius SE & Co KGaA, Medical Equipment, Deals By Type, 2011 to YTD 2017 39
Fresenius SE & Co KGaA, Recent Deals Summary 40
Currency Codes 53
Capital Market Ratios 53
Equity Ratios 54
Profitability Ratios 54
Cost Ratios 55
Liquidity Ratios 55
Leverage Ratios 56
Efficiency Ratios 56
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.